Loading data for BAX — first visit, this takes a few seconds.

Alerta

Baxter International Inc. (BAX)

NYSE: BAX · Precio en tiempo real · USD

26.53

+0.59 (2.27%)

Al cierre: Aug 19, 2026, 4:57 PM

2.27% (1D)

No hay datos disponibles

Precio de compra	26.48
Capitalización de mercado	13.72B
Ingresos (TTM)	11.47B
Beneficio neto (TTM)	-968M
Beta	0.59
EPS (TTM)	-1.88
Ratio PER (TTM)	n/a
Adelante PE	13.03
P/B (TTM)	2.21
P/S (TTM)	1.20
Earnings Date	Oct 29, 2026

Precio de venta	26.5
Volumen	1,897,611
Volumen medio (20D)	7,031,929
Abierto	26.04
Anterior Cerrar	25.94
Rango del día	25.87 - 26.75
Rango de 52 semanas	15.73 - 30.00
analista	n/a
Precio objetivo	n/a
Dividendos	$0.04 (0.15%)
Fecha ex dividendo	28 ago 2026

Acerca de BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant produ...

[Leer más]

Industria Medical Instruments & Supplies

Sector Healthcare

IPO Fecha Oct 27, 1981

Empleados 37,500

Bolsa de Valores NYSE

Símbolo bursátil BAX

Sitio web https://www.baxter.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Baxter International fueron 11.24B, un aumento de 5.72% en comparación con 10.64B del año anterior. Las ganancias fueron -957M, un aumento de 47.46%.

Estados financieros

Sorpresa de resultados

Baxter International ha publicado sus resultados trimestrales en Jul 30, 2026:

Ingresos de $2.96B falla las estimaciones por $0, con 5.34% Crecimiento interanual.

EPS de 0.56 supera las estimaciones en 0.19, con -5.08% Disminución interanual.

Próxima publicación de resultados

Está previsto que Baxter International Inc. publique sus resultados el Oct 29, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

3 días hace · StockStory

3 Stocks Under $50 with Questionable Fundamentals

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune t...

4 días hace · Zacks

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

6 días hace · Zacks

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

1 semana hace · Simply Wall St.

Does Cardinal Health’s New CAO and Recalls Reveal Shifts in Its Risk Profile and Earnings Quality (CAH)?

In early August 2026, Cardinal Health announced that Anita Zielinski will become Chief Accounting Officer in November, following her interim CFO and senior accounting roles at Baxter and long tenure a...

2 semanas hace · Simply Wall St.

Baxter (BAX) Stock Gets Fair Value Boost After Q2 Beat And Higher Targets

Baxter International is back in focus after the fair value estimate in one widely used model moved from US$21.54 to US$27.29, a change of about 27% that feeds directly into updated price target discus...

Página 1 de 2

Baxter International Inc. (BAX)